Middle East and Africa Automated Cell Cultures Market, By Product (Consumables, Instruments), Type (Infinite Cell Line Cultures, Finite Cell Line Cultures), Application (Drug Development, Stem Cell Research, Regenerative Medicine, Cancer Research, Vaccines, Others), End User (Biotech Companies, Research Organizations, Academic Research Institutes, Other) Industry Trends and Forecast to 2029.
Middle East and Africa Automated Cell Cultures Market Analysis and Insights
The automated cell cultures market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Middle East and Africa automated cell cultures market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.6% in the forecast period of 2022 to 2029 and is expected to reach EURO 270.93 million by 2029. Increasing demand of cell culture technology in vaccine production, and Wide acceptance of cell culture techniques in various applications are the major drivers which propelled the demand of the market in the forecast period.
Report Metric |
Details |
Forecast Period |
2022 to 2029 |
Base Year |
2021 |
Historic Years |
2020 (Customizable to 2019 - 2014) |
Quantitative Units |
Revenue in EURO Million, Volumes in Units, Pricing in EURO |
Segments Covered |
By Product (Consumables, Instruments), Type (Infinite Cell Line Cultures, Finite Cell Line Cultures), Application (Drug Development, Stem Cell Research, Regenerative Medicine, Cancer Research, Vaccines, Others), End User (Biotech Companies, Research Organizations, Academic Research Institutes, Other). |
Countries Covered |
South Africa, Rest of Middle East and Africa |
Market Players Covered |
Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG and Others |
Middle East and Africa Automated Cell Cultures Market Definition
Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.
Middle East and Africa Automated Cell Cultures Market Dynamics
This section deals with understanding the market drivers, opportunity, restraint, and challenge. All of this is discussed in detail below:
- Drivers
Increasing Demand for Cell Culture Technology in Vaccine Production
Cell culture is an essential tool for molecular and cellular biology research. Today, most biotechnology products primarily rely on mass culturing cell lines. Cell cultures have applications in diverse areas and serve as a model system for numerous research efforts.
An increase in funding from the government for cell-based research is significantly triggering the market's growth. In addition, cell culture techniques are widely being used as an alternative to current egg-based strategies for developing cell-based vaccines. Cell culture has potential applications in developing viral vaccines with increased communicable diseases and pandemic risk. Thus, cell culture technology is being extensively used in developing U.S. licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio.
Technological Advancements in Cell Culture Technology Systems
As the demand for advanced cell culture technologies in vaccine production, cancer research, and virology, among others, is increasing, certain technological developments are taking place in automated cell culture.
Thus, market players operating in the market adopt various technological developments in cell culture equipment to boost their business in various dimensions and lead to market growth. This factor could drive the Middle East and Africa automated cell cultures market growth.
- Restraint
High Cost of Automated Cell Culture Systems
The cost of the product is the major setback for the market as it is expected to decrease the demand due to high cost. In the case of automated cell culture systems, the price is also high, and below the given instance will showcase the product's price.
The instruments and consumables-related products such as cell counters, reagents, buffers, and others have high prices, which shows that the cost of automated cell cultures is the primary factor expected to restrain the Middle East and Africa automated cell cultures market in the forecasted period.
- Opportunity
New Product Launches and Technology Developments
Pharmaceutical and biotechnology-driven companies are working towards developing and launching new products and technologies for automated cell culture advancement and making the treatment and diagnosis methods more reachable. This has also increased the demand for an automated cell culture market for 3D cell cultures. The development of new bioreactors, platforms, softwares has led to an advancement in the automated cell culture market and its growth.
The new products and technologies launched and worked upon create good opportunities for the Middle East and Africa automated cell cultures market. The new platforms with advanced technologies act as a footstep closer to the advancement of the market.
- Challenge
Development and Maintenance of Expertise
Recruitment and retention of trained and qualified staff, staff development, capital budgets for equipment purchase, operating budget management, facility infrastructure, and change management all require proper attention for the growth and success of any market. Failure to meet needs in any of these areas can lead to a serious weakness that, if uncorrected, may compromise the credibility of a laboratory and create a situation that will be difficult to correct in the short term.
Testing and maintaining the level of expertise in testing laboratories is a tough task, and it needs high experience, which sometimes is not accessible, which causes the development process for a particular company to hinder. Thus it is anticipated to challenge the Middle East and Africa automated cell cultures market growth in the forecasted period.
Recent Developments
- In July 2021, BD launched bdbiosciences.com, an updated digital marketplace for flow cytometry. The new website provides an enhanced online purchasing experience for flow cytometry users and their procurement teams
- In January 2021, Hamilton Company joined its high-throughput automated workflow ingenuity with Artel’s performance testing expertise so that users may be assured of robust and continuous automated liquid handling workstation performance integrity. Artel and Hamilton will co-develop standard automated scripts for Hamilton’s automated workstations as part of the collaboration
Middle East and Africa Automated Cell Cultures Market Scope
Middle East and Africa automated cell cultures market is segmented into Product, Type, Application, and End User. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Middle East And Africa Automated Cell Cultures Market, By Product
- Consumables
- Instruments
On the basis of product, the Middle East and Africa automated cell cultures market is segmented into consumables and instruments
Middle East And Africa Automated Cell Cultures Market, By Type
- Infinite Cell Line Cultures
- Finite Cell Line Cultures
On the basis of type, the Middle East and Africa automated cell cultures market is segmented into infinine Cell line cultures and finite Cell line cultures
Middle East And Africa Automated Cell Cultures Market, By Application
- Drug Development
- Stem Cell Research
- Regenerative Medicine
- Cancer Research
- Vaccines
- Others
On the basis of application, the Middle East and Africa automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccine and others.
Middle East And Africa Automated Cell Cultures Market, By End User
- Biotech Companies
- Research Organizations
- Academic Research Institutes
- Other
On the basis of end user, the Middle East and Africa automated cell cultures market is segmented into biotech companies, research organizations, academic research institutes and others.
Middle East and Africa Automated Cell Cultures Market Regional Analysis/Insights
The Middle East and Africa automated cell cultures market is analyzed and market size information is provided by Product, Type, Application, and End User.
The countries covered in this market report are South Africa, Rest of Middle East and Africa.
- In 2022, The Middle East and Africa automated cell cultures market is expected to grow due to increasing applications in stem cell research, vaccine production, regenerative medicines production, and drug discovery.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Middle East and Africa Automated Cell Cultures Market Share Analysis
Middle East and Africa automated cell cultures market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Middle East and Africa automated cell cultures market.
The key market players for Middle East and Africa automated cell cultures Market are Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, Advanced Instruments,Benchmark scientific, Inc., BioSpherix, Ltd., Biotron Healthcare, Bulldog Bio, Cell Culture Company, LLC, CellGenix GmbH, ChemoMetec, Corning Incorporated, Cytiva (Subsidiary of Danahar Corporation), FUJIFILM Holdings America Corporation, Hemilton Company, Hitachi, Ltd., Kawasaki Heavy Industries, ltd., HiMedia Laboratories, NanoEntek America, Inc., Nexcelom Bioscience LLC., PromoCell GmbH, RWD Life Science Co., LTD, Sartorius AG, Scientica Instrumentation, Inc., SHIBUYA CORPORATION, Sphere Fluidics Limited, Tecan Trading AG,Thrive Bioscience, Inc., and Others.
Research Methodology: Middle East and Africa Automated Cell Cultures Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Middle East and Africa vs Regional, and Vendor Share Analysis. Please request analyst call in case of further inquiry.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORK FOR MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS
6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS
6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS
6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES
6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT
6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS
6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS
6.3.3 INCREASING OUTSOURCING FACILITIES
6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE
6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES
7 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 CONSUMABLES
7.2.1 MEDIA
7.2.1.1 SERUM FREE MEDIA
7.2.1.2 CLASSICAL MEDIA & SALTS
7.2.1.3 STEM CELL CULTURE MEDIA
7.2.1.4 SPECIALTY MEDIA
7.2.2 BUFFERS AND SUPPLEMENTS
7.2.2.1 PLASMA
7.2.2.2 SERA
7.2.2.3 FETAL BOVINE SERA
7.2.2.4 ADULT BOVINE SERA
7.2.2.5 OTHERS ANIMAL SERA
7.2.3 REAGENTS
7.2.3.1 SUPPLEMENTS & GROWTH FACTORS
7.2.3.2 BUFFERS & CHEMICALS
7.2.3.3 CELL DISASSOCIATION REAGENTS
7.2.3.4 BALANCED SALT SOLUTIONS
7.2.3.5 ATTACHMENT & MATRIX FACTORS
7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS
7.2.3.7 CONTAMINATION DETECTION KITS
7.2.3.8 CRYOPROTECTIVE REAGENTS
7.2.3.9 OTHERS CELL CULTURE REAGENTS
7.2.4 ACCESSORIES
7.3 INSTRUMENTS
7.3.1 SUPPORTING EQUIPMENTS
7.3.1.1 CELL COUNTERS
7.3.1.2 IMAGE BASED CELL COUNTERS
7.3.1.3 FLOW CYTOMETERS
7.3.1.4 COULTER COUNTERS
7.3.1.5 CELL EXPANSION
7.3.1.6 LIQUID HANDLERS
7.3.1.7 OTHERS
7.3.2 BIOREACTORS
7.3.2.1 SINGLE USE BIOREACTORS
7.3.2.2 CONVENTIONAL BIOREACTORS
7.3.2.3 OTHERS
7.3.3 STORAGE EQUIPMENTS
7.3.3.1 REFRIGERATORS & FREEZERS
7.3.3.2 CRYOSTORAGE SYSTEMS
7.3.3.3 OTHERS
8 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY TYPE
8.1 OVERVIEW
8.2 INFINITE CELL LINE CULTURES
8.3 FINITE CELL LINE CULTURES
9 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DEVELOPMENT
9.3 STEM CELL RESEARCH
9.3.1 EMBRYONIC STEM CELLS
9.3.2 TISSUE-SPECIFIC STEM CELLS
9.3.3 MESENCHYMAL STEM CELLS
9.3.4 INDUCED PLURIPOTENT STEM CELLS
9.4 REGENERATIVE MEDICINE
9.4.1 STEM CELL THERAPY
9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)
9.4.3 TISSUE ENGINEERING
9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS
9.5 CANCER RESEARCH
9.6 VACCINES
9.7 OTHERS
10 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY END USER
10.1 OVERVIEW
10.2 BIOTECH COMPANIES
10.3 RESEARCH ORGANIZATIONS
10.4 ACADEMIC RESEARCH INSTITUTES
10.5 OTHERS
11 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY REGION
11.1 MIDDLE EAST & AFRICA
11.1.1 SOUTH AFRICA
11.1.2 REST OF MIDDLE EAST AND AFRICA
12 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
13 COMPANY PROFILE
13.1 LONZA
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.1.6 SWOT ANALYSIS
13.2 MERCK KGAA
13.2.1 COMPANY SNAPSHOT
13.2.2 RECENT FINANCIALS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.2.6 SWOT ANALYSIS
13.3 THERMO FISHER SCIENTIFIC INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 RECENT FINANCIALS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.3.6 SWOT ANALYSIS
13.4 BD
13.4.1 COMPANY SNAPSHOT
13.4.2 RECENT FINANCIALS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.4.6 SWOT ANALYSIS
13.5 EPPENDORF AG
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.5.6 SWOT ANALYSIS
13.6 ADVANCED INSTRUMENTS
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENTS
13.7 BENCHMARK SCIENTIFIC INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 BIOSPHERIX LTD.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENTS
13.9 BIOTRON HEALTHCARE
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 BULLDOG-BIO, INC.
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.11 CELL CULTURE COMPANY, LLC
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
13.12 CELLGENIX GMBH
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 CHEMOMETEC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 CORNING INCORPORATED
13.14.1 COMPANY SNAPSHOT
13.14.2 RECENT FINANCIALS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 FUJIFILM HOLDINGS AMERICA CORPORATION
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 HAMILTON COMPANY
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENTS
13.18 HITACHI, LTD.
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 KAWASAKI HEAVY INDUSTRIES, LTD.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENTS
13.2 HIMEDIA LABORATORIES
13.20.1 COMPANY SNAPSHOT
13.20.2 PRODUCT PORTFOLIO
13.20.3 RECENT DEVELOPMENTS
13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
13.22 NEXCELOM BIOSCIENCE LLC.
13.22.1 COMPANY SNAPSHOT
13.22.2 PRODUCT PORTFOLIO
13.22.3 RECENT DEVELOPMENTS
13.23 PROMOCELL GMBH
13.23.1 COMPANY SNAPSHOT
13.23.2 PRODUCT PORTFOLIO
13.23.3 RECENT DEVELOPMENTS
13.24 RWD LIFE SCIENCE CO LTD.
13.24.1 COMPANY SNAPSHOT
13.24.2 PRODUCT PORTFOLIO
13.24.3 RECENT DEVELOPMENTS
13.25 SARTORIUS AG
13.25.1 COMPANY SNAPSHOT
13.25.2 REVENUE ANALYSIS
13.25.3 PRODUCT PORTFOLIO
13.25.4 RECENT DEVELOPMENTS
13.26 SCIENTICA INSTRUMENTATION, INC.
13.26.1 COMPANY SNAPSHOT
13.26.2 PRODUCT PORTFOLIO
13.26.3 RECENT DEVELOPMENTS
13.27 SHIBUYA CORPORATION
13.27.1 COMPANY SNAPSHOT
13.27.2 RECENT FINANCIALS
13.27.3 PRODUCT PORTFOLIO
13.27.4 RECENT DEVELOPMENTS
13.28 SPHERE FLUIDICS LIMITED
13.28.1 COMPANY SNAPSHOT
13.28.2 PRODUCT PORTFOLIO
13.28.3 RECENT DEVELOPMENTS
13.29 TECAN TRADING AG
13.29.1 COMPANY SNAPSHOT
13.29.2 RECENT FINANCIALS
13.29.3 PRODUCT PORTFOLIO
13.29.4 RECENT DEVELOPMENT
13.3 THRIVE BIOSCIENCE, INC.
13.30.1 COMPANY SNAPSHOT
13.30.2 PRODUCT PORTFOLIO
13.30.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 2 MIDDLE EAST & AFRICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 4 MIDDLE EAST & AFRICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 5 MIDDLE EAST & AFRICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 6 MIDDLE EAST & AFRICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)
TABLE 7 MIDDLE EAST & AFRICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 8 MIDDLE EAST & AFRICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 9 MIDDLE EAST & AFRICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 10 MIDDLE EAST & AFRICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 11 MIDDLE EAST & AFRICA STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 12 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 13 MIDDLE EAST & AFRICA INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 14 MIDDLE EAST & AFRICA FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 15 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 16 MIDDLE EAST & AFRICA DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 17 MIDDLE EAST & AFRICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 18 MIDDLE EAST & AFRICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 19 MIDDLE EAST & AFRICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 20 MIDDLE EAST & AFRICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 21 MIDDLE EAST & AFRICA CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 22 MIDDLE EAST & AFRICA VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 23 MIDDLE EAST & AFRICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 24 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 25 MIDDLE EAST & AFRICA BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 26 MIDDLE EAST & AFRICA RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 27 MIDDLE EAST & AFRICA ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 28 MIDDLE EAST & AFRICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 29 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)
TABLE 30 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 31 MIDDLE EAST AND AFRICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 32 MIDDLE EAST AND AFRICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 33 MIDDLE EAST AND AFRICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 34 MIDDLE EAST AND AFRICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 35 MIDDLE EAST AND AFRICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 36 MIDDLE EAST AND AFRICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 37 MIDDLE EAST AND AFRICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 38 MIDDLE EAST AND AFRICA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 39 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 40 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 41 MIDDLE EAST AND AFRICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 42 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 43 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 44 SOUTH AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 45 SOUTH AFRICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 46 SOUTH AFRICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 47 SOUTH AFRICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 48 SOUTH AFRICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 49 SOUTH AFRICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 50 SOUTH AFRICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 51 SOUTH AFRICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 52 SOUTH AFRICA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 53 SOUTH AFRICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 54 SOUTH AFRICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 55 SOUTH AFRICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 56 SOUTH AFRICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 57 SOUTH AFRICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 58 REST OF MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD
FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET
FIGURE 14 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021
FIGURE 15 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)
FIGURE 16 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 17 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021
FIGURE 19 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)
FIGURE 20 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 21 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021
FIGURE 23 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)
FIGURE 24 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 25 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2021
FIGURE 27 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)
FIGURE 28 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)
FIGURE 31 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)
FIGURE 32 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)
FIGURE 35 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.